This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Symkevi - Tezacaftor with Ivacaftor

Vertex

Description

Mucolytic to facilitate expectoration by reducing sputum viscosity in the case of cystic fibrosis.

By mouth
Child 6–11 years (body-weight up to 30 kg): 50/75 mg, to be taken in the morning and, Ivacaftor 75 mg to be taken in the evening (about 12 hours apart).
Child 6–11 years (body-weight 30 kg and above): 100/150 mg, to be taken in the morning and, Ivacaftor 150 mg to be taken in the evening (about 12 hours apart).
Child 12–17 years: 100/150 mg, to be taken in the morning and, Ivacaftor 150 mg to be taken in the evening (about 12 hours apart).
Adult: 100/150 mg, to be taken in the morning in combination with Ivacaftor 150 mg in the evening.

Indications

Mucolytic to facilitate expectoration by reducing sputum viscosity in the case of cystic fibrosis.

Contraindications

In the case of hepatic impairment, only use if the benefits outweigh the risks. 

Preparations Available

Tablets

Sizes Available

Tablets
Symkevi 50 mg/75 mg, 28 tablets
Symkevi 100 mg/150 mg, 28 tablets

More on: Mucolytics , Tezacaftor with Ivacaftor